Clinical Study of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Clinical Study of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors	cancer, neoplasm	Active, not recruiting	Phase 1	2026-03-09		NCT05707910

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
West China Hospital	359

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
West China Hospital	Chengdu	China	47

Clinical trials